Green, Lawrence J.
Bhatia, Neal D.
Toledano, Ofer
Erlich, Maya
Spizuoco, Amy
Goodyear, Benjamin C.
York, Jean Philippe
Jakus, Jeannette
Article History
Received: 31 July 2023
Revised: 31 July 2023
Accepted: 6 September 2023
First Online: 4 October 2023
Declarations
:
: LJG is an investigator, speaker, or consultant to: Abbvie, Alumis, Arcutis, Amgen, BMS, Cara, Dermavant, DermTech, Highlittl, Janssen, Lilly, Novan, OrthoDerm, SunPharma, Takeda, UCB, Ventyx, Verrica. NDB is an advisor, consultant, and investigator for Galderma and Sol-Gel Technologies. OT and ME are employees of Sol-Gel Technologies. AS is a speaker for Diversity in Dermatology and the American Osteopathic College of Dermatology; had employment or consultation with Amgen, Ortho Dermatologics, Galderma, Regeneron/Sanofi, BMS, Arcutis, Dermavant, Eli Lilly, CeraVe, Verrica; and had a position on advisory board or board of directors or other type of management relationships with: Amgen, Ortho Dermatologics, Galderma, Regeneron/Sanofi, BMS, Arcutis, Dermavant, Eli Lilly, CeraVe, and Verrica. BCG and JPY are employees of Galderma Laboratories. JJ is an investigator in Galderma clinical trials unrelated to the subject matter of this manuscript. She is an investigator and speaker for other companies, none of which represent a conflict of interest for this publication.
: LJG is an investigator, speaker, or consultant to: Abbvie, Alumis, Arcutis, Amgen, BMS, Cara, Dermavant, DermTech, Highlittl, Janssen, Lilly, Novan, OrthoDerm, SunPharma, Takeda, UCB, Ventyx, Verrica. NDB is an advisor, consultant, and investigator for Galderma and Sol–Gel Technologies. OT and ME are employees of Sol–Gel Technologies. AS is a speaker for Diversity in Dermatology and the American Osteopathic College of Dermatology; had employment or consultation with Amgen, Ortho Dermatologics, Galderma, Regeneron/Sanofi, BMS, Arcutis, Dermavant, Eli Lilly, CeraVe, Verrica; and had a position on advisory board or board of directors or other type of management relationships with: Amgen, Ortho Dermatologics, Galderma, Regeneron/Sanofi, BMS, Arcutis, Dermavant, Eli Lilly, CeraVe, and Verrica. BCG and JPY are employees of Galderma Laboratories. JJ is an investigator in Galderma clinical trials unrelated to the subject matter of this manuscript. She is an investigator and speaker for other companies, none of which represent a conflict of interest for this publication.